companydata.dkRenescience A/S: Financial statements 2016
CVR: 31846803
Renescience A/S (CVR 31846803) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK -37,068,000 and a net result of DKK -29,521,000 compared with DKK -43,214,000 the year before. Equity amounted to DKK 89,546,000. The solvency ratio was 88.6%.
- Gross Profit
- -37,068,000 kr.
- Profit/Loss
- -29,521,000 kr.
- Equity
- 89,546,000 kr.
- Total Assets
- 101,054,000 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | -37.1 mio. | -29.5 mio. | 89.5 mio. | - |
| 2015 | - | -56 mio. | -43.2 mio. | 24.1 mio. | - |
| 2014 | - | -26.4 mio. | -19.4 mio. | 33.3 mio. | - |
| 2013 | - | -25.6 mio. | -19.9 mio. | 27.7 mio. | - |
| 2012 | - | -21 mio. | -16.6 mio. | 17.6 mio. | - |
How creditworthy is Renescience A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2016
As of June 1, 2016, Niels Henriksen has joined the board of directors of Renescience A/S.
As of June 1, 2016, Jacob Moesgård has joined the board of directors of Renescience A/S.
As of June 1, 2016, Thomas Dalsgaard has joined the board of directors of Renescience A/S.
As of June 1, 2016, Anna-Lena Elisabet Jeppsson has left the board of directors of Renescience A/S.
As of June 1, 2016, Ole Thomsen has left the board of directors of Renescience A/S.
As of June 1, 2016, Anna-Lena Elisabet Jeppsson is registered as director of Renescience A/S.
As of June 1, 2016, Niels Henriksen has stepped down as director of Renescience A/S.
As of May 31, 2016, Jacob Moesgård has left the board of directors of Renescience A/S.
Renescience A/S has published its annual report for 2015. Gross profit came to DKK -55,972,000, and the net result was DKK -43,214,000.
As of April 15, 2016, Anna-Lena Elisabet Jeppsson has joined the board of directors of Renescience A/S.
About Renescience A/S
Renescience A/S is a Danish company of the type Aktieselskab based in Fredericia, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Lars Holm Lerke-Møller. The company is owned by Ørsted New Bio Solutions Holding A/S. In 2025, the company reported revenue of DKK 21,000 and a net result of DKK -503,937,000 compared with DKK -23,904,000 the year before. Equity amounted to DKK 73,470,000.